The Optics of Health Care Reform

 
• By Michael McCaughan

There are plenty of reasons Wall Street doesn’t like health care reform. The biggest one, though, may be how hard it is to see over a cliff—the patent cliff that is resetting valuations across the Big Pharma sector.

Going over a cliff is one thing. Seeing over it should be much easier.

But, at least for now, Wall Street isn't ready to take in the view. How else to explain the drumbeat...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet